CClinicalTrials.gg
Not yet recruitingNCT07797868Updated Sep 1, 2026

Vacuum-Assisted Closure Versus Graduated Primary Skin Closure for Postoperative Burst Abdomen

An interventional study of Vacuum-Assisted Closure (VAC) Therapy and Graduated Primary Skin Closure in Abdominal Wound Dehiscence, Burst Abdomen and Surgical Wound Dehiscence, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Burst abdomen, or complete abdominal wound dehiscence, is a severe postoperative complication characterized by the separation of the musculo-aponeurotic layer of the abdominal wall. It leads to extended hospital stays, high treatment costs, and an increased risk of long-term incisional hernia. While negative pressure wound therapy using vacuum-assisted closure (VAC) is widely utilized, graduated (staged) primary skin closure remains a common, accessible bedside alternative. Direct randomized comparative evidence evaluating these two approaches for established burst abdomen is limited.

The main objective of this study is to compare the clinical effectiveness and safety of vacuum-assisted closure (VAC) versus graduated primary skin closure in the management of postoperative burst abdomen.

Participants will be randomly assigned (1:1) to one of two groups:

  1. VAC Group: Patients will receive continuous negative pressure wound therapy (-75 to -125 mmHg) applied via a specialized polyurethane foam and adhesive dressing, with changes performed every 48 to 72 hours until sufficient granulation tissue forms for definitive closure.
  2. Graduated Closure Group: Patients will undergo progressive re-approximation of the wound edges using full-thickness retention sutures placed under local anesthesia and tightened incrementally every 48 to 72 hours until complete closure is achieved.

The primary outcome of the study is the time to achieve complete fascial and cutaneous wound closure. Secondary outcomes include total length of hospital stay, incidence of surgical site infections, pain scores during procedures, wound recurrence, and incisional hernia formation during follow-up.

02

Conditions studied

  • Abdominal Wound Dehiscence
  • Burst Abdomen
  • Surgical Wound Dehiscence

Keywords

  • Negative Pressure Wound Therapy
  • Vacuum-Assisted Closure
  • NPWT
  • Graduated Primary Skin Closure
  • Staged Closure
  • Abdominal Wall Defect
  • Postoperative Complications
  • Incisional Hernia
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients aged 18 years or older of either sex
  • Clinically confirmed complete (full-thickness) postoperative burst abdomen following a midline or paramedian laparotomy
  • Medically fit to tolerate bedside wound management/re-intervention (hemodynamically stable, not requiring vasopressor support)
  • Patient or legal guardian willing and able to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Planned or pre-existing open abdomen (laparostomy) at the index operation
  • Presence of enterocutaneous or enteroatmospheric fistula at the wound site
  • Uncontrolled intra-abdominal sepsis or ongoing hemodynamic instability precluding safe wound management
  • Known hypersensitivity or allergy to polyurethane foam or adhesive drape materials used in VAC systems
  • Active malignancy with peritoneal carcinomatosis where wound closure is not a treatment priority
  • Pregnancy
  • Refusal to participate or to be randomized
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Vacuum-Assisted Closure (VAC)

    Participants in this arm receive negative pressure wound therapy (NPWT) using an open-cell polyurethane foam dressing, fenestrated adhesive drape, and continuous sub-atmospheric pressure standardized between -75 and -125 mmHg. A non-adherent protective layer is interposed over exposed bowel loops. Dressing changes and wound assessments are performed under aseptic technique every 48 to 72 hours until sufficient granulation tissue forms to permit secondary suturing or delayed primary closure.

    Procedure: Vacuum-Assisted Closure (VAC) Therapy

  • Active comparator
    Graduated Primary Skin Closure

    Participants in this arm undergo bedside staged/graduated primary wound closure using full-thickness interrupted monofilament retention sutures with bolsters/bridges across the abdominal wall under local anesthesia. Sutures are progressively approximated and tightened in sequential sessions every 48 to 72 hours (mirroring the dressing change interval) to avoid tension-related tissue ischemia until complete fascial and skin apposition is achieved.

    Procedure: Graduated Primary Skin Closure

Interventions

  • ProcedureVacuum-Assisted Closure (VAC) Therapy

    Under aseptic technique, non-viable tissue is debrided and the wound irrigated with normal saline. An open-cell polyurethane foam is trimmed to fit the wound cavity (with a non-adherent protective layer over exposed bowel), sealed with an adhesive drape, and connected to continuous sub-atmospheric pressure (-75 to -125 mmHg). Dressing changes and assessments are conducted every 48 to 72 hours until sufficient granulation tissue permits definitive closure.

  • ProcedureGraduated Primary Skin Closure

    Full-thickness interrupted retention monofilament sutures with protective bolsters/bridges are placed across the abdominal wall under local anesthesia at the bedside. Sutures are progressively tightened and approximated in sequential sessions every 48 to 72 hours to minimize tissue ischemia and tension until complete fascial and cutaneous apposition is achieved.

05

What researchers measure

Primary outcomes

  1. Time to Complete Wound Closure

    Measured as the number of days elapsed from the date of randomization until complete fascial and skin apposition of the abdominal wound is achieved, verified by clinical examination.

    Time frame: 30 days

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT07797868
Lead sponsor
Assiut University
Responsible party
Karmy Hany Farouk (Resident, Assiut University) — Principal investigator
First posted
Sep 1, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 1, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion